U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274202) titled 'The Physical and Mental Impact of ART: IVM vs Conventional Ovarian Stimulation' on Nov. 27.
Brief Summary: Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine conditions, affecting around 10% of women in reproductive age (ESHRE PCOS guideline, 2023).
PCOS is a heterogeneous condition characterized by a combination of Polycystic Ovarian Morphology (PCOM) on ultrasound scan, oligo- or amenorrhea and/or hyperandrogenism. Women diagnosed with PCOS are known to have a higher risk for type 2 diabetes mellitus, cardiovascular pathology, pregnancy complications and an impaired quality of life (QoL) (Borghi et al., 2017; ES...